Prof Andrew Wei
Honorary (Professorial Fellow)
Department of Medical Biology (WEHI)
571 Scholarly works
4 Projects
HIGHLIGHTS
2025
Research grants (other domestic)
COSMOS-AML; Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML
2024
Research grants (other domestic)
Investigating Clonal Haematopoiesis and Risk Factors for Evolution to Myeloid Neoplasia (ICHROME)
2023
Journal article
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia
DOI: 10.1182/blood.20220160902022
Journal article
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL
DOI: 10.1182/blood.20210127752021
Journal article
BCL2 and MCL1 inhibitors for hematologic malignancies
DOI: 10.1182/blood.20200067852021
Journal article
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias
DOI: 10.1182/blood.20200101672020
Journal article
BAX-Mutated Clonal Hematopoiesis in Patients on Long-Term Venetoclax for Relapsed/Refractory Chronic Lymphocytic Leukemia
DOI: 10.1182/blood-2020-137775
RECENT SCHOLARLY WORKS
2026
Journal article
Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide
DOI: 10.1038/s41408-025-01429-z2026
Journal article
Timing of response in patients with relapsed/refractory FLT3mut acute myeloid leukemia treated with gilteritinib
DOI: 10.1016/j.bneo.2026.1002702026
Journal article
RAS seals fate in AML besieged by FLT3 and BCL2 inhibitors
DOI: 10.1182/blood.20260348772026
Journal article
Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study
DOI: 10.1200/JCO-25-006172026
Journal article
MAP3K14 (NIK) synonymous variants drive altered splicing to activate NF-κB in mature B-cell malignancies.
DOI: 10.1182/blood.20260342282026
Journal article
Neutropenia Duration During AZA-VEN Induction for AML Is Bimodal and Correlates With Infection Risk.
DOI: 10.1182/bloodadvances.20260209892026
Journal article
ELN-DAVID recommendations for NGS-based FLT3-ITD MRD testing for patients with acute myeloid leukemia
DOI: 10.1182/blood.20260335692026
Journal article
BCL-2 and MCL1 co-inhibition enhances glucocorticoid therapy in preclinical models of infant KMT2A-rearranged acute lymphoblastic leukaemia
DOI: 10.1111/bjh.70598